atrial fibrillation

The consensus statement, published this week, should help to guide decision-making around genetic testing for a variety of cardiac conditions.

The prospective analysis suggests that the approach could help clinicians identify patients at risk of a stroke who could benefit from anticoagulant treatment.

Backed by €19 million in EU funding, the initiative, called BigData@Heart, will create a research platform that could change the way cardiovascular diseases are diagnosed and treated.